Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,536.80
(
0.07%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
96.50
(
-0.30%
)
Bitcoin
70,246.00
(
-0.92%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: jbog post# 177170

Wednesday, 04/23/2014 6:27:59 AM

Wednesday, April 23, 2014 6:27:59 AM

Post# of 257275
If VRUS was worth $11 Billion, is it unreasonable for ENTA to be worth $5 Billion?

http://www.businesswire.com/news/home/20111121005623/en/Gilead-Sciences-Acquire-Pharmasset-11-Billion#.U1eVUfldXlc

I will be happy with even a $3 Billion buyout. VRUS when it was acquired, was not as far along as ENTA is now. I don't understand why ENTA is still so cheap. Isn't this derisked more than VRUS was when it was acquired?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today